DNAJB3 and hyperlipidemia: The chronic conditions associated with obesity such as low grade metabolic inflammation, hyperlipidemia, and enhanced oxidative and ER stress responses promoted us to explore the possible mechanisms involved in modulating the expression of DNAJB3.